Parameter | Group I | Group II | P value |
---|---|---|---|
Overall survival (months) | 48.40+/-65,966 | 43.78+/- 39.736 | 0.319 |
1-year survival rate | 137 (50.2%) | 203 (71.5%) | 0.013 |
2-years survival rate | 110 (40.3%) | 150 (52.8%) | 0.083 |
5-year survival rate | 64 (23.4%) | 101 (35.6%) | 0.021 |
IA | 11 (61.1%) | 25 (83.3%) | 0.644 |
IB | 22 (73.3%) | 33 (70.2%) | 1.000 |
IIA | 17 (39.5%) | 23 (37.7%) | 1.000 |
IIB | 7 (13.7%) | 13 (27.7%) | 0.221 |
IIIA | 7 (12.1%) | 5 (7.7%) | 0.552 |
IIIB | 0 | 2 (8.3%) | 0.111 |
IIIC | 0 | 0 | - |
Deaths | 209 (76.6%) | 183 (64.4%) | 0.210 |
Gastric cancer related | 193 (92.3%) | 166 (90.7%) | 0.942 |
Other causes | 16 (7.7%) | 17 (9.3%) | 0.717 |